Fermer le menu


Member of Lyonbiopole


Allogenica is a Lyon-based biotechnology company specialized in the development of allogenic CAR-T cells (Chimeric Antigen Receptor T-cells).

Allogenica has developed a bioproduction platform that relies on the manipulation of hematopoietic stem cells and their derivatives with the aim of developing allogenic "off-the-shelf" CAR-T cells.

Allogenica's ambition is to offer the next-generation cancer treatment ready to use, at low cost and safer than current treatments, in order to treat all patients in need.


Application market: Bioproduction, Hematology, Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Cell Therapy - Stem cells - Cell Biology - Biobanking, Gene Therapy, Immunotherapy

Created on jan. 22nd, 2022 - 5 employees



47 boulevard du onze novembre 1918, CS 90170 69625 Villeurbanne Cedex



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.